Subscribe to Daily Review - your favourite M&A deals update.

Submit Deal

NORDIC BIOSCIENCE

Summary

Nordic Bioscience is a biomarker extracellular matrix specialist, which offers customized development of highly disease-specific biochemical markers for diagnosis and prognosis of various diseases.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 72 M

Avg. Deal Size£ 72 M

Market Context

Senior Management

Morten Karsdal
CEO
Thomas Nielsen
CFO
Claus Christiansen
Founder and Chairman

Sort

anuv ratan

Principal at KKR & CO

Investor

Shared Deals

2 Opposite

£ 143 M

Total Value

alice neave

Senior Associate at Finsbury Glover Hering

PR Consultant

Shared Deal

1 Opposite

£ 72 M

Total Value

anders borg

Managing Director at KKR & CO

Investor

Shared Deal

1 Opposite

£ 72 M

Total Value

alastair elwen

Director at Finsbury Glover Hering

PR Consultant

London

Shared Deal

1 Opposite

£ 72 M

Total Value

wim de vlieger

Partner at Sidley Austin

Lawyer

London

Shared Deal

1 Opposite

£ 72 M

Total Value

henry r. kravis

CEO at KKR & CO

Investor

Shared Deal

1 Opposite

£ 72 M

Total Value

robert lewin

CFO at KKR & CO

Investor

New York

Shared Deal

1 Opposite

£ 72 M

Total Value

george r. roberts

CEO at KKR & CO

Investor

Shared Deal

1 Opposite

£ 72 M

Total Value

hillary roberts

Senior Consultant at Kromann Reumert

Lawyer

London

Shared Deal

1 Opposite

£ 72 M

Total Value

jakob hans johansen

Partner at Kromann Reumert

Lawyer

Shared Deal

1 Opposite

£ 72 M

Total Value

kugan sathiyanandarajah

Director at KKR & CO

Investor

Shared Deal

1 Opposite

£ 72 M

Total Value

peter choi

Senior Counsel at Sidley Austin

Lawyer

Shared Deal

1 Opposite

£ 72 M

Total Value

See 24 dealmakers that match your search results with a free MergerLinks account.

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy